Who
John Kenneth Jenkins
Director
Company insider
Files Form 4 as: Director, Corbus Pharmaceuticals Holdings; Director, Provention Bio.
In numbers
- Trades disclosed
- 25
- Buys
- 1
- Sells
- 2
- Bought
- $6,980
- Sold
- $96K
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 5 Jun 2018
- Last trade
- 10 Jun 2026
- Last filed
- 11 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 10 Jun 2026filed 11 Jun 2026 | CRBP Corbus Pharmaceuticals HoldingsBiotechnology | SEC FORM 4 Sold | $38K4,800 at $7.91 | filing |
| 10 Jun 2026filed 11 Jun 2026 | CRBP Corbus Pharmaceuticals HoldingsBiotechnology | SEC FORM 4 Sold | $38K4,800 at $7.91 | filing |
| 19 May 2026filed 21 May 2026 | CRBP Corbus Pharmaceuticals HoldingsBiotechnology | SEC FORM 4 Code A | —3,800 at $0.00 | filing |
| 19 May 2026filed 21 May 2026 | CRBP Corbus Pharmaceuticals Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —12,300 at $0.00 | filing |
| 19 May 2026filed 21 May 2026 | CRBP Corbus Pharmaceuticals Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —12,300 at $0.00 | filing |
| 19 May 2026filed 21 May 2026 | CRBP Corbus Pharmaceuticals HoldingsBiotechnology | SEC FORM 4 Code A | —3,800 at $0.00 | filing |
| 30 May 2025filed 2 Jun 2025 | CRBP Corbus Pharmaceuticals Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —16,000 at $0.00 | filing |
| 30 May 2025filed 2 Jun 2025 | CRBP Corbus Pharmaceuticals HoldingsBiotechnology | SEC FORM 4 Sold | $20K2,783 at $7.35 | filing |
| 30 May 2025filed 2 Jun 2025 | CRBP Corbus Pharmaceuticals HoldingsBiotechnology | SEC FORM 4 Code A | —4,800 at $0.00 | filing |
| 30 May 2024filed 3 Jun 2024 | CRBP Corbus Pharmaceuticals HoldingsBiotechnology | SEC FORM 4 Code A | —2,783 at $0.00 | filing |
| 16 May 2024filed 20 May 2024 | CRBP Corbus Pharmaceuticals Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,783 at $0.00 | filing |
| 18 May 2023filed 22 May 2023 | CRBP Corbus Pharmaceuticals Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —5,300 at $0.00 | filing |
| 27 Apr 2023filed 27 Apr 2023 | Provention Biooption or derivative | SEC FORM 4 Code D | —128,981 | filing |
| 27 Apr 2023filed 27 Apr 2023 | Provention Biooption or derivative | SEC FORM 4 Code D | —23,000 | filing |
| 27 Apr 2023filed 27 Apr 2023 | Provention Biooption or derivative | SEC FORM 4 Code D | —33,000 | filing |
| 18 May 2022filed 19 May 2022 | CRBP Corbus Pharmaceuticals Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —79,600 at $0.00 | filing |
| 17 May 2022filed 18 May 2022 | Provention Biooption or derivative | SEC FORM 4 Code A | —33,000 at $0.00 | filing |
| 17 Jun 2021filed 17 Jun 2021 | CRBP Corbus Pharmaceuticals Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —58,200 at $0.00 | filing |
| 17 Jun 2021filed 17 Jun 2021 | CRBP Corbus Pharmaceuticals Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —58,200 at $0.00 | filing |
| 12 May 2021filed 14 May 2021 | Provention Biooption or derivative | SEC FORM 4 Code A | —23,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.